Lisanti Capital Growth, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Lisanti Capital Growth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$121.19 - $165.49 $1.13 Million - $1.54 Million	-9,285 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$104.21 - $156.44 $420,070 - $630,609	4,031 Added 76.72%	9,285 $1.38 Million
Q1 2020 May 11, 2020	BUY	$93.12 - $133.99 $14,806 - $21,304	159 Added 3.12%	5,254 $572,000
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $379,628 - $632,951	5,095 New	5,095 $587,000

585

104M

2.82M

1.75M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.